Cargando…

The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review

BACKGROUND AND OBJECTIVE: Cholangiocarcinoma (CCA), a liver cancer of bile duct epithelial cells, is a severe health issue in northeastern Thailand. The epithelial-mesenchymal transition (EMT) is a crucial process in the development of CCA. To comprehend oncogenic EMT in CCA, several newly found EMT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimawaha, Phongsaran, Techasen, Anchalee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331758/ https://www.ncbi.nlm.nih.gov/pubmed/37435208 http://dx.doi.org/10.21037/jgo-22-1126

Ejemplares similares

Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms
por: Kimawaha, Phongsaran, et al.
Publicado: (2021)

Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis
por: Jamnongkan, Wassana, et al.
Publicado: (2018)

Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma
por: Tessiri, Supharada, et al.
Publicado: (2022)

Novel clinical therapeutics targeting the epithelial to mesenchymal transition
por: Kothari, Anai N, et al.
Publicado: (2014)

Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
por: Yao, Xing, et al.
Publicado: (2012)

Narrative review: mesenchymal-epithelial transition inhibitors—meeting their target
por: Safi, Danish, et al.
Publicado: (2021)

ARID1A alterations and their clinical significance in cholangiocarcinoma
por: Namjan, Achira, et al.
Publicado: (2020)

Epithelial–Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma
por: Sawanyawisuth, Kanlayanee, et al.
Publicado: (2021)

Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress
por: Chaiprasert, Timpika, et al.
Publicado: (2019)

Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines
por: Promraksa, Bundit, et al.
Publicado: (2019)

CD44 variant‐dependent redox status regulation in liver fluke‐associated cholangiocarcinoma: A target for cholangiocarcinoma treatment
por: Thanee, Malinee, et al.
Publicado: (2016)

Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis
por: Phanthaphol, Nattaporn, et al.
Publicado: (2017)

Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma
por: Loilome, Watcharin, et al.
Publicado: (2017)

Metabolic Changes of Cholangiocarcinoma Cells in Response to Coniferyl Alcohol Treatment
por: Promraksa, Bundit, et al.
Publicado: (2021)

Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma
por: Jamnongkan, Wassana, et al.
Publicado: (2019)

Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients
por: Huang, Xiao-Yong, et al.
Publicado: (2014)

Periostin promotes malignant potential by induction of epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma
por: Mino, Masaaki, et al.
Publicado: (2017)

Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition–An Outstanding Challenge
por: Fintha, Attila, et al.
Publicado: (2019)

In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues
por: Suksawat, Manida, et al.
Publicado: (2019)

Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth
por: Padthaisong, Sureerat, et al.
Publicado: (2018)

Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy
por: Suksawat, Manida, et al.
Publicado: (2018)

FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells
por: Yang, Hui, et al.
Publicado: (2015)

Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?
por: Brivio, Simone, et al.
Publicado: (2015)

Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma
por: Zhang, Tong-Jun, et al.
Publicado: (2017)

Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process
por: Dana, Paweena, et al.
Publicado: (2017)

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
por: Di Gregorio, Jacopo, et al.
Publicado: (2020)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer
por: Zhong, Weilong, et al.
Publicado: (2023)

Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem
por: Hughes, Thomas, et al.
Publicado: (2017)

Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway
por: Khophai, Sasikamon, et al.
Publicado: (2018)

Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients
por: Chua-on, Daraporn, et al.
Publicado: (2020)

Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway
por: Daya, Minerva, et al.
Publicado: (2018)

FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling
por: Lu, Zhaoyang, et al.
Publicado: (2014)

Fascin Induces Epithelial-Mesenchymal Transition of Cholangiocarcinoma Cells by Regulating Wnt/β-Catenin Signaling
por: Mao, Xianhai, et al.
Publicado: (2016)

MSI2 knockdown represses extrahepatic cholangiocarcinoma growth and invasion by inhibiting epithelial–mesenchymal transition
por: Hu, Feihu, et al.
Publicado: (2018)

CCR7 Mediates Cell Invasion and Migration in Extrahepatic Cholangiocarcinoma by Inducing Epithelial–Mesenchymal Transition
por: Oba, Mitsunobu, et al.
Publicado: (2023)

Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)

Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
por: Datta, Arpita, et al.
Publicado: (2021)

Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition
por: Duan, Xirui, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma
por: Wintachai, Preawwalee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3kit4lgnccdr4odui461qh36db